Fatigue, a common symptom in clinical practice, often presents a diagnostic challenge due to its multifactorial etiology. A comprehensive approach is required to accurately diagnose and manage this condition.
Fatigue is a subjective feeling of tiredness or exhaustion that is chronic and debilitating. It is a common complaint in primary care, affecting up to 20% of all patients. It can be associated with a wide range of medical conditions, including sleep disorders, endocrine diseases, cardiovascular conditions, and psychiatric disorders.
The clinical evaluation of fatigue should be systematic and thorough. It should include a detailed history and physical examination, supplemented by targeted laboratory investigations. The history should focus on the onset, duration, and severity of fatigue, as well as its impact on daily activities. The physical examination should aim to identify signs of underlying systemic disease.
The diagnostic approach to fatigue should be guided by the clinical findings. If the history and physical examination suggest a specific cause, appropriate diagnostic tests should be performed. If no specific cause is identified, a broad-based approach should be adopted, including complete blood count, thyroid function tests, and tests for chronic infections.
The management of fatigue should be tailored to the underlying cause. In cases where no specific cause is identified, management should focus on symptom relief and improvement of quality of life. This may include lifestyle modifications, cognitive behavioral therapy, and pharmacological treatment.
Fatigue is a complex symptom that requires a comprehensive clinical approach for effective diagnosis and management. By understanding its multifactorial nature and adopting a systematic evaluation strategy, healthcare professionals can better identify the underlying causes and implement appropriate treatment plans.
1.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
2.
Health researchers discuss Medicaid cancer screening trends, best practices
3.
Taking Charge of Your Cancer Journey.
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
3.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
4.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
5.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation